U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07435259) titled 'Comparing Implant Retention Versus Removal for MRONJ at Implant Sites' on Feb. 20.
Brief Summary: Medication-related osteonecrosis of the jaw (MRONJ) is a condition that can occur in patients who take medications such as antiresorptive drugs for osteoporosis and other bone-related systemic diseases. Although the overall risk is relatively low, the number of affected patients is increasing as the population ages and dental implants are increasingly used to restore chewing function. When MRONJ develops at an implant site, deciding whether to keep or remove the implant becomes a difficult clinical problem.
Current treatment recommenda...